Treatment of the metabolic syndrome by siRNA targeting apolipoprotein CIII.
Biofactors
; 49(1): 153-172, 2023 Jan.
Article
in En
| MEDLINE
| ID: mdl-36039858
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Metabolic Syndrome
/
Diabetes Mellitus, Type 2
Type of study:
Guideline
Limits:
Animals
Language:
En
Journal:
Biofactors
Journal subject:
BIOQUIMICA
Year:
2023
Document type:
Article
Affiliation country:
Suecia
Country of publication:
Países Bajos